Skip to main navigation
Loading
  • News
  • Investors
  • Careers
  • Contact
  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Expanded Access Policy
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Products
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Information
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home
  • Menu Menu

Events & Presentations

  • Overview
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Analyst Coverage
  • Press Releases
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • IRS – Required Disclosures
  • SEC Filings
    • Quarterly Results
  • Contact
  • Email Alerts

Company Presentation

  • Zevra Corporate Presentation - March 2023

    03-08-2023

  • Zevra Quarterly Results Presentation – Q4 and FY 2022 Results

    03-07-2023

Upcoming Events

More events are coming soon.

Past Events

Consero Global IP Management and IP Life Sciences Virtual Forum
06-07-2021 4:00 PM EDT
Register for webcast
KemPharm Q1 2021 Corporate Update Call
05-13-2021 4:30 PM EDT
Listen to webcast
Amendment to the KP415 License Agreement Conference Call
04-08-2021 4:30 PM EDT
Transcript link
33rd Annual Roth Conference
03-15 - 03-17-2021
Listen to webcast
KemPharm Q4 2020 Corporate Update Call
03-11-2021 4:30 PM EST
Listen to webcast
Click here for transcript and audio replay
AZSTARYS™ (KP415) FDA Approval Conference Call
03-03-2021 8:30 AM EST
Listen to webcast
Click here for transcript and audio replay
KP415 Market Opportunity and Commercialization Strategy
12-02-2020 10:00 AM EST
Listen to webcast
Click here for transcript and audio replay
Special Meeting of Stockholders
11-17-2020 8:00 AM EST
KemPharm Q3 2020 Corporate Update Call
10-29-2020 4:30 PM EDT
Listen to webcast
Click here for transcript and audio replay
Virtual Life Science Investor Forum
09-17-2020 10:30 AM EDT
Listen to webcast
Pagination
  • First page «
  • Previous page ‹
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Next page ›
  • Last page »
  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Expanded Access Policy
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Products
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Information
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home

© 2023 Zevra Therapeutics, Inc. All rights reserved. Privacy Policy | Terms of Use

Scroll to top